Since 2011, Medicines New Zealand has rewarded outstanding researchers for undertaking innovative research into the use of medicines or vaccines through the Value of Medicines Award. In 2022 Medicines New Zealand relaunched the award scheme, after a brief hiatus due in part to the COVID-19 Pandemic.
The Award Scheme now includes two awards:
- The Innovation Jump Start Award designed to provide financial assistance for an early career researcher.
- The Award for Excellence in Innovative Medicines Research which recognises an already established researcher for the contribution they have made to biopharmaceutical research in New Zealand.
Applications for the 2023 Innovation Jump Start Award have now closed.
2023 marks the second year of the Innovation Jump Start Award. This Award aims to give a jump start boost to the career of one of New Zealand’s potential future leaders in biopharmaceutical innovation.
Designed to support a new or continuing project in the area of drug disovery and development, the Innovation Jump Start Award will be awarded to one of New Zealand’s potential future leaders in biopharmaceutical innovation.
The award is intended to financially support a promising researcher’s ability to reach their career goals in medicines development.
Member companies of Medicines New Zealand will also be able to assist the award recipient, by researching out to their networks of international affiliate companies in order to gain opportunities for industry experience.
This Award is open to applications from early career scientists including current postgraduate students (Masters and PhD Candidates) in life-science disciplines which are relevant to the biopharmaceutical sectors such as pharmacology, genetics, physiology, biochemistry and immunology to Health Care Professionals who are pursuing a research-focussed career.
As the Award is intended for early career researchers, applicants’ highest qualification is anticipated to have been conferred within the past ten (10) years.
Value of the Award
The Award recipient will receive a prize package with a total value of up to $30,000* NZD. This includes:
$20,000 to support project costs.
Career support funding of up to $10,000 to enable the winner to participate in an educational programme or another career-enhancing opportunity (industry internship etc).
*Total value of up to $30,000 exclusive of GST
A serendipitous observation made during Dr Wade's research has led to the identification of a protein with significant potential for development into a biological therapeutic to improve post-surgical healing of the fascia after abdominal surgeries such as hernia repairs, caesarean sections, and surgery for pelvic prolapse. If the findings of her proposed research are positive and it is feasible to develop a biological therapeutic product using this protein, it would have the potential to improve outcomes for a vast range of people and could save the health system money by avoiding the need for repeat surgeries.
The second award available this year is The Award for Excellence in Innovative Medicines Research. It continues the traditions of the earlier Value of Medicines Award (2011-2018) which was awarded for an outstanding research project involving innovative use of medicines or vaccines. The Award for Excellence in Innovative Medicines Research recognises a New Zealander who has made a significant scientific or clinical contribution to the development of innovative medicines or vaccines. The Award takes a broad view of success and is designed to recognise and celebrate the efforts of an established New Zealand researcher to ensure that the biopharmaceutical research sector thrives in New Zealand.
The award winner, to be selected by Medicines New Zealand, will be presented with the Value of Medicines Trophy in recognition of their significant contribution to innovative medicines research in New Zealand.
Professor Robson has been a principal investigator on more than 70 clinical trials and as an author on approximately 100 publications. He has gone above and beyond in his commitment to innovative biopharmaceutical research in New Zealand through his decades of involvement with the Health Research Council’s Standing Committee on Therapeutic Trials (SCOTT).
Dr Emma Wade
Smart biologicals to enhance internal healing
Dr Nicholas Lightfoot
Modernising local anaesthesiology
Dr Conroy Wong
Dr Sally Eyers
Safe paediatric use of paracetamol
Professor Lisa Stamp
Gout management research
Dr Paul Young
ICU fever management
Professor Ian Reid
Treatment of Osteoporosis
Dr Amy Chan
Paediatric asthma management
Dr Swee Tan
Strawberry birthmark research